Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer

E-ISSN： 1873-5576|12|2|144-163

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.2, 2012-02, pp. : 144-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Aurora kinases in ovarian cancer

By Fu Siqing Hu Wei Kavanagh John J Bast Jr Robert C

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 77-85

Informa Healthcare

Access to resources Recommend Favorite

Targeting Aurora Kinases in Cancer Treatment

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2067-2078

Bentham Science Publishers

Access to resources Recommend Favorite

Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-05 ,pp. : 915-920

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Aurora kinases for the treatment of cancer

By Fancelli Daniele Moll Jürgen

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1169-1182

Informa Healthcare

Access to resources Recommend Favorite

New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 290-302

Bentham Science Publishers

Access to resources Recommend Favorite